U.S. Regulation of Stem Cells as Medical Products

The Promise and Perils of Stem Cell Therapeutics

(2012) George Q. Daley   Cell Stem Cell

China’s stem-cell rules go unheeded

(2012) David Cyranoski   NATURE

Tourism ban won't help Indian tigers

(2012) Ralf C. Buckley et al.   NATURE

Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials

(2012) Manoj M. Lalu et al.   PLoS One

Improving oversight of innovative medical interventions in Texas, USA

(2012) Aaron D Levine   Regenerative Medicine

Texas Medical Board Approves Rules for Controversial Treatment

(2012) J. Kaiser   SCIENCE

Catastrophic Demyelinating Encephalomyelitis After Intrathecal and Intravenous Stem Cell Transplantation in a Patient With Multiple Sclerosis

(2011) Yazan J. Alderazi et al.   JOURNAL OF CHILD NEUROLOGY

Are You "Tilting at Windmills" or Undertaking a Valid Clinical Trial?

(2011) John D. Steeves et al.   YONSEI MEDICAL JOURNAL

Defining the risks of mesenchymal stromal cell therapy

(2010) Darwin J. Prockop et al.   CYTOTHERAPY

Time-dependent fate of transplanted neural precursor cells in experimental autoimmune encephalomyelitis mice

(2010) Angeliki Giannakopoulou et al.   EXPERIMENTAL NEUROLOGY

Angiomyeloproliferative Lesions Following Autologous Stem Cell Therapy

(2010) D. Thirabanjasak et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

FDA Regulation of Stem Cell-Based Products

(2009) D. W. Fink   SCIENCE